Skip to content

Plasma technology combined with traditional Chinese medicine to improve keloid susceptibility in the treatment of hyperplastic keloid scars

Plasma technology combined with traditional Chinese medicine to improve keloid susceptibility in the treatment of hyperplastic keloid scars

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400085537
Enrollment
Unknown
Registered
2024-06-12
Start date
2024-06-17
Completion date
Unknown
Last updated
2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

scar

Interventions

experimental group:Micro-Plasma Radiofrequency combined with Traditional Chinese Medicine Improves Physical Fitness Treatment
control group:Micro-plasma radiofrequency therapy

Sponsors

Chinese PLA General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
10 Years to 60 Years

Inclusion criteria

Inclusion criteria: ? Patient is 10-60 years old and in good general condition; ? Suffering from more than 1 proliferative scar, the site is not limited; ? Diagnosed as damp-heat constitution by Chinese medicine practitioners; ? The duration of the disease is more than 1 year; ? Have not received other methods of treatment; ? Those who voluntarily accept the treatment and cooperate with long-term follow-up.

Exclusion criteria

Exclusion criteria: ?Patients with combined heart, brain, liver, kidney, lung, blood system and other serious diseases; ? Those who are pregnant, breastfeeding or planning to be pregnant; ? Those who are suffering from mental diseases and cannot cooperate with the treatment.

Design outcomes

Primary

MeasureTime frame
Vancouver Scar Scale;

Secondary

MeasureTime frame
Scar itching and pain score;

Countries

China

Contacts

Public ContactMinliang Chen

Chinese PLA General Hospital

brq9762@163.com+86 155 3377 1167

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026